APA (7th ed.) Citation

Mallardo, D., Woodford, R., Menzies, A. M., Zimmer, L., williamson, A., Ramelyte, E., . . . Ascierto, P. A. (2023). The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab. Journal of translational medicine, 21(1), 1-11. https://doi.org/10.1186/s12967-023-04607-4

Chicago Style (17th ed.) Citation

Mallardo, Domenico, et al. "The Role of Diabetes in Metastatic Melanoma Patients Treated with Nivolumab Plus Relatlimab." Journal of Translational Medicine 21, no. 1 (2023): 1-11. https://doi.org/10.1186/s12967-023-04607-4.

MLA (9th ed.) Citation

Mallardo, Domenico, et al. "The Role of Diabetes in Metastatic Melanoma Patients Treated with Nivolumab Plus Relatlimab." Journal of Translational Medicine, vol. 21, no. 1, 2023, pp. 1-11, https://doi.org/10.1186/s12967-023-04607-4.